British Airways Pensions Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-102,590
Closed -$9.7M 98
2018
Q3
$9.7M Hold
102,590
0.36% 76
2018
Q2
$9.51M Buy
102,590
+840
+0.8% +$82K 0.37% 75
2018
Q1
$9.63M Buy
+101,750
New +$11.2M 0.34% 78
2015
Q3
Sell
-266,840
Closed -$17.9M 126
2015
Q2
$17.9M Hold
266,840
0.55% 82
2015
Q1
$15.6M Hold
266,840
0.48% 98
2014
Q4
$17.5M Buy
+266,840
New +$16.8M 0.57% 74

Other funds holding ABBV

British Airways Pensions Investment Management's ABBV Position: Q4 2018 in Review

British Airways Pensions Investment Management sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 102,590 shares — an estimated $9.7M sold.

British Airways Pensions Investment Management first reported a position in ABBV in Q4 2014 and held it in 6 quarters. The position peaked at $17.9M in Q2 2015. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • British Airways Pensions Investment Management reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • British Airways Pensions Investment Management sold 102,590 AbbVie shares in Q4 2018, an estimated $9.7M.
  • British Airways Pensions Investment Management first reported a position in AbbVie in Q4 2014 and held it in 6 quarters.
  • British Airways Pensions Investment Management's AbbVie position peaked at $17.9M in Q2 2015.
  • 2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on British Airways Pensions Investment Management's 13F filing for Q4 2018, filed 15 Feb 2019.